Altogether, these data suggest a pro-oncogenic role for FOXO6, downstream of GBM-associated elevated FOXG1, in the regulatory transitions that must be initiated as cells move from quiescence to proliferation. This evidence concerns the gene FOXO6 and glioblastoma.